Erratum: Expression of Concern: “α-Zearalanol attenuates oxLDL-induced ET-1 gene expression, ET-1 secretion and redox-sensitive intracellular signaling activation in human umbilical vein endothelial cells” [Toxicology Letters 179 (3) (10 July 2008) 163–168] (163–168), (S0378427408001380), (10.1016/j.toxlet.2008.05.005);α-Zearalanol attenuates oxLDL-induced ET-1 gene expression, ET-1 secretion and redox-sensitive intracellular signaling activation in human umbilical vein endothelial cells

Toxicology Letters

Volumn 179, Issue 3, 2008, Pages 163-168

  Xu, Haishan ^a   Duan, Jinhong ^a   Dai, Shunling ^a   Wu, Yunqing ^a   Sun, Renyu ^a   Ren, Jun ^a,b  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b UNIVERSITY OF WYOMING   (United States)

Author keywords

Endothelial cells; ET 1; oxLDL; ROS; Transcriptional factor; ZAL

Indexed keywords

ACETYLCYSTEINE; ENDOTHELIN 1; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR AP 1; ZERANOL;

ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; METHODOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN; UPREGULATION;

EID: 45849114357     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2024.04.008     Document Type: Erratum

References (35)

1. Agapitov A.V., and Haynes W.G. Role of endothelin in cardiovascular disease. J. Renin Angiotensin Aldosterone Syst. 3 (2002) 1-15
2. Canderelli R., Leccesse L.A., Miller N.L., and Unruh D.J. Benefits of hormone replacement therapy in postmenopausal women. J. Am. Acad. Nurse Pract. 19 (2007) 635-641
3. Clarkson T.B. Soy phytoestrogens: what will be their role in postmenopausal hormone replacement therapy?. Menopause 7 (2000) 71-75
4. Dai S., Duan J., Lu Y., Cheng J., Ren J., Deng W., and Wu Y. Alpha-zearalanol, a phytoestrogen for cardiovascular therapy. Endocrine 25 (2004) 117-119
5. Dai S., Duan J., Lu Y., Zhang Y., Cheng J., Ren J., Zhao X., Wu Y., Yu Y., Zuo P., Wu Y., and Ge Q. Phytoestrogen alpha-zearalanol inhibits atherogenesis and improves lipid profile in ovariectomized cholesterol-fed rabbits. Endocrine 25 (2004) 121-129
6. Delerive P., Martin-Nizard F., Chinetti G., Trottein F., Fruchart J.C., Najib J., Duriez P., and Staels B. Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ. Res. 85 (1999) 394-402
7. Duan J., Dai S., Fang C.X., Sun R., Shavali S., Sharma S.K., Ebadi M., and Ren J. Phytoestrogen alpha-zearalanol antagonizes homocysteine-induced imbalance of nitric oxide/endothelin-1 and apoptosis in human umbilical vein endothelial cells. Cell Biochem. Biophys. 45 (2006) 137-145
8. Duan J., Xu H., Dai S., Wang X., Wu Y., Zhang Y., Sun R., and Ren J. Phytoestrogen alpha-zearalanol inhibits homocysteine-induced endothelin-1 expression and oxidative stress in human umbilical vein endothelial cells. Atherosclerosis 197 (2008) 549-555
9. Feng R., Bowman L.L., Lu Y., Leonard S.S., Shi X., Jiang B.H., Castranova V., Vallyathan V., and Ding M. Blackberry extracts inhibit activating protein 1 activation and cell transformation by perturbing the mitogenic signaling pathway. Nutr. Cancer 50 (2004) 80-89
10. Goraca A. New views on the role of endothelin (minireview). Endocr. Regul. 36 (2002) 161-167
11. Gottstein N., Ewins B.A., Eccleston C., Hubbard G.P., Kavanagh I.C., Minihane A.M., Weinberg P.D., and Rimbach G. Effect of genistein and daidzein on platelet aggregation and monocyte and endothelial function. Br. J. Nutr. 89 (2003) 607-616
12. Hernandez-Perera O., Perez-Sala D., Navarro-Antolin J., Sanchez-Pascuala R., Hernandez G., Diaz C., and Lamas S. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J. Clin. Invest. 101 (1998) 2711-2719
13. Hsu Y.H., Chen J.J., Chang N.C., Chen C.H., Liu J.C., Chen T.H., Jeng C.J., Chao H.H., and Cheng T.H. Role of reactive oxygen species-sensitive extracellular signal-regulated kinase pathway in angiotensin II-induced endothelin-1 gene expression in vascular endothelial cells. J. Vasc. Res. 41 (2004) 64-74
14. Hwang J., Wang J., Morazzoni P., Hodis H.N., and Sevanian A. The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification. Free Radic. Biol. Med. 34 (2003) 1271-1282
15. Ihling C., Bohrmann B., Schaefer H.E., Technau-Ihling K., and Loeffler B.M. Endothelin-1 and endothelin converting enzyme-1 in human atherosclerosis--novel targets for pharmacotherapy in atherosclerosis. Curr. Vasc. Pharmacol. 2 (2004) 249-258
16. Juan S.H., Chen J.J., Chen C.H., Lin H., Cheng C.F., Liu J.C., Hsieh M.H., Chen Y.L., Chao H.H., Chen T.H., Chan P., and Cheng T.H. 17beta-estradiol inhibits cyclic strain-induced endothelin-1 gene expression within vascular endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H1254-H1261
17. Koh K.K., Blum A., Hathaway L., Mincemoyer R., Csako G., Waclawiw M.A., Panza J.A., and Cannon III R.O. Vascular effects of estrogen and vitamin E therapies in postmenopausal women. Circulation 100 (1999) 1851-1857
18. Liu J.C., Chen J.J., Chan P., Cheng C.F., and Cheng T.H. Inhibition of cyclic strain-induced endothelin-1 gene expression by resveratrol. Hypertension 42 (2003) 1198-1205
19. Maggi-Capeyron M.F., Ceballos P., Cristol J.P., Delbosc S., Le Doucen C., Pons M., Leger C.L., and Descomps B. Wine phenolic antioxidants inhibit AP-1 transcriptional activity. J. Agric. Food Chem. 49 (2001) 5646-5652
20. Matsuura E., Kobayashi K., Tabuchi M., and Lopez L.R. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog. Lipid Res. 45 (2006) 466-486
21. Mohandas B., and Mehta J.L. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease. Curr. Opin. Cardiol. 22 (2007) 434-442
22. Naderi G.A., Asgary S., Sarraf-Zadegan N., and Shirvany H. Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation. Mol. Cell Biochem. 246 (2003) 193-196
23. Rathel T.R., Leikert J.F., Vollmar A.M., and Dirsch V.M. The soy isoflavone genistein induces a late but sustained activation of the endothelial nitric oxide-synthase system in vitro. Br. J. Pharmacol. 144 (2005) 394-399
24. Schachter M. The pathogenesis of atherosclerosis. Int. J. Cardiol. 62 Suppl 2 (1997) S3-S7
25. Shi J., Wang X., Qiu J., Si Q., Sun R., Guo H., and Wu Q. Roles of NF-kappaB and SP-1 in oxidative stress-mediated induction of platelet-derived growth factor-B by TNFalpha in human endothelial cells. J. Cardiovasc. Pharmacol. 44 (2004) 26-34
26. Siow R.C., Li F.Y., Rowlands D.J., de Winter P., and Mann G.E. Cardiovascular targets for estrogens and phytoestrogens: transcriptional regulation of nitric oxide synthase and antioxidant defense genes. Free Radic. Biol. Med. 42 (2007) 909-925
27. Spirichev V.B. Antioxidant vitamins in the treatment and prevention of cardiovascular diseases. Vitamin E. Vopr. Pitan. 72 (2003) 45-51
28. Takaoka M., Ohkita M., and Matsumura Y. Pathophysiological role of proteasome-dependent proteolytic pathway in endothelin-1-related cardiovascular diseases. Curr. Vasc. Pharmacol. 1 (2003) 19-26
29. Wagner A.H., Schroeter M.R., and Hecker M. 17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J. 15 (2001) 2121-2130
30. Wallerath T., Deckert G., Ternes T., Anderson H., Li H., Witte K., and Forstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106 (2002) 1652-1658
31. Watanabe T., Pakala R., Katagiri T., and Benedict C.R. Lysophosphatidylcholine is a major contributor to the synergistic effect of mildly oxidized low-density lipoprotein with endothelin-1 on vascular smooth muscle cell proliferation. J. Cardiovasc. Pharmacol. 39 (2002) 449-459
32. Xu H., Duan J., Wang W., Dai S., Wu Y., Sun R., and Ren J. Reactive oxygen species mediate oxidized LDL-induced endothelin-1 gene expression via extracellular signal-regulated kinase (ERK) pathway in vascular endothelial cells. J. Hypertens. 26 (2008) 956-963
33. Xu H.S., Duan J., Dai S., Wu Y., Sun R., and Ren J. Phytoestrogen alpha-zearalanol antagonizes oxidized LDL-induced inhibition of nitric oxide production and stimulation of endothelin-1 release in human umbilical vein endothelial cells. Endocrine 25 (2004) 235-245
34. Yamashita K., Discher D.J., Hu J., Bishopric N.H., and Webster K.A. Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, and p300/CBP. J. Biol. Chem. 276 (2001) 12645-12653
35. Ye G., Metreveli N.S., Ren J., and Epstein P.N. Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes 52 (2003) 777-783